Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,359
datasets available to search
ShareScore release 0.9.0
Dataset results
4,359 results for “Insulin”
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
ClinicalTrials.gov study NCT01519674. IPD Sharing: Not stated. Countries: 10. Publications: 1.
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
ClinicalTrials.gov study NCT03730662. IPD Sharing: YES. Countries: 15. Publications: 6.
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
ClinicalTrials.gov study NCT01089569. IPD Sharing: NO. Countries: 1. Publications: 2.
Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents
ClinicalTrials.gov study NCT00516386. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02128932. IPD Sharing: Not stated. Countries: 15. Publications: 12.
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
ClinicalTrials.gov study NCT02079805. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
ClinicalTrials.gov study NCT02168491. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
ClinicalTrials.gov study NCT00082407. IPD Sharing: Not stated. Countries: 12. Publications: 3.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT01621178. IPD Sharing: YES. Countries: 9. Publications: 2.
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
ClinicalTrials.gov study NCT00976391. IPD Sharing: YES. Countries: 14. Publications: 1.
Effect of Vitamin D3 Supplementation on Insulin Resistance- The DIR Study
ClinicalTrials.gov study NCT01889810. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01326026. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
ClinicalTrials.gov study NCT01232946. IPD Sharing: NO. Countries: 1. Publications: 1.
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabe
ClinicalTrials.gov study NCT00960661. IPD Sharing: Not stated. Countries: 18. Publications: 1.
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT03882970. IPD Sharing: YES. Countries: 13. Publications: 9.
Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01272193. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02030600. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
ClinicalTrials.gov study NCT02104804. IPD Sharing: Not stated. Countries: 1. Publications: 7.
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
ClinicalTrials.gov study NCT04760626. IPD Sharing: YES. Countries: 8. Publications: 6.
Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM
ClinicalTrials.gov study NCT01855243. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.